SUPPLY AGREEMENT BETWEEN CENTRO DE CONSTRUCCION DE CARDIOESTIMULADORES DEL URUGUAY S.A. AND NEVRO CORP. March 13, 2015Supply Agreement • March 18th, 2015 • Nevro Corp • Surgical & medical instruments & apparatus • Delaware
This supply agreement (“Agreement”) is entered into on March 13, 2015 (the “Effective Date”) by and between Centro de Construccion de Cardioestimuladores del Uruguay S.A. (“CCC”), an Uruguay corporation with its principal place of business at General Paz 1371, Montevideo, Uruguay, CP 11400 and Nevro Corp. (“Nevro”), a Delaware corporation with its principal place of business at 4040 Campbell Avenue, Suite 210, Menlo Park, CA 94025. CCC and Nevro are referred to collectively as the “Parties”, individually as a “Party.”
FIRST AMENDMENT TO THE PRODUCT SUPPLY AND DEVELOPMENT AGREEMENTProduct Supply and Development Agreement • March 18th, 2015 • Nevro Corp • Surgical & medical instruments & apparatus
This FIRST AMENDMENT TO THE PRODUCT SUPPLY AND DEVELOPMENT AGREEMENT (“Amendment”), effective as of March 1, 2015 (the “Effective Date”), is by and between EaglePicher Medical Power LLC (“EPMP LLC”), a Delaware Corporation having an address of “C” and Porter Streets, Joplin, MO 64801 and Nevro Corp. (“Buyer”), a Delaware Corporation, having its principal place of business at 4040 Campbell Avenue, Suite 210, Menlo Park, CA 94025.
SECOND AMENDMENT TO LEASELease • March 18th, 2015 • Nevro Corp • Surgical & medical instruments & apparatus
This Second Amendment to Lease (“Second Amendment”) is entered into as of February 18, 2015 (“Reference Date”), by and between Deerfield Campbell LLC, a California limited liability company (hereinafter called “Landlord”), and Nevro Corp., a Delaware corporation (hereinafter called “Tenant”), with reference to the following facts:
FIRST AMENDMENT TO TERM LOAN AGREEMENTTerm Loan Agreement • March 18th, 2015 • Nevro Corp • Surgical & medical instruments & apparatus • Texas
THIS FIRST AMENDMENT TO TERM LOAN AGREEMENT (this “Amendment”), dated as of March 9, 2015 (the “First Amendment Effective Date”), is made among NEVRO CORP., a Delaware corporation (the “Borrower”), and the financial institutions listed on the signature pages hereof under the heading “LENDERS” (each a “Lender” and, collectively, the “Lenders”).
